Kent and Medway
Joint Medicines Formulary

Drugs Acting on the Renin-Angiotensin System

NICE Guidance

TA388: Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction

TA1074: Sparsentan for treating primary IgA nephropathy

Sacubitril/Valsartan (Entresto)

Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.

Sparsentan

East Kent Hospital University Foundation Trust ONLY High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary